New report centers on prescription drugs

A new report aims to bring stricter laws to stop price gouging by drug companies The report says a group of "gray market" drug companies pull in hundreds of millions of dollars in profits each year by buying needed pharmaceuticals and selling them at inflated prices. Cancer patients are a particular target. A joint Congressional investigation cited the lack of government rules and regulations to control this secondary market as a problem that faces not only West Virginia, but the entire country. The study was partially commissioned by Sen. Jay Rockefeller, who said it's important lawmakers make sure prescription drugs are affordable.